AAAAAA

   
Results: 1-19 |
Results: 19
Inhibitory conditioning stimulus in transcranial magnetic stimulation reduces the number of excited spinal motor neurons
Authors: Mall, V Glocker, FX Fietzek, U Heinen, F Berweck, S Korinthenberg, R Rosler, KM
Citation: V. Mall et al., Inhibitory conditioning stimulus in transcranial magnetic stimulation reduces the number of excited spinal motor neurons, CLIN NEU, 112(10), 2001, pp. 1810-1813
Commentary on the article by Bakheit et al. - 'Opinion statement on the minimal standards for healthcare in cerebral palsy'
Authors: Heinen, F
Citation: F. Heinen, Commentary on the article by Bakheit et al. - 'Opinion statement on the minimal standards for healthcare in cerebral palsy', DISABIL REH, 23(13), 2001, pp. 586-586
Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option
Authors: Kirschner, J Berweck, S Mall, V Korinthenberg, R Heinen, F
Citation: J. Kirschner et al., Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option, J NEUROL, 248, 2001, pp. S28-S30
On being a child and having children with the changing times
Authors: Aksu, F Thyen, U Hanefeld, F Auerswald, G Christen, HJ Faust, J Gabriel, R Genzel, O Haas, D Hasselmann, O Heinen, F Karch, D Kirschstein, M Kluger, G Korn-Merker, E Krageloh-Mann, I Marg, W Mayatepek, E Meissner, T Niemann, G Pust, B Schmitt, B Schoening, M Schulze, A Sperner, J Tegtmeyer, FK Weisert, M Wiebicke, W Wilken, B Zschocke, J Bentele, K Schinzel, A Strassburg, M
Citation: F. Aksu et al., On being a child and having children with the changing times, MONATS KIND, 149(6), 2001, pp. 594-596
Recommendations for the use of botulinum toxin type A in the management ofcerebral palsy
Authors: Graham, HK Aoki, KR Autti-Ramo, I Boyd, RN Delgado, MR Gaebler-Spira, DJ Gormley, ME Guyer, BM Heinen, F Holton, AF Matthews, D Molenaers, G Motta, F Ruiz, PJG Wissel, J
Citation: Hk. Graham et al., Recommendations for the use of botulinum toxin type A in the management ofcerebral palsy, GAIT POSTUR, 11(1), 2000, pp. 67-79
Management of spasticity associated pain with botulinum toxin A
Authors: Wissel, J Muller, J Dressnandt, J Heinen, F Naumann, M Topka, H Poewe, W
Citation: J. Wissel et al., Management of spasticity associated pain with botulinum toxin A, J PAIN SYMP, 20(1), 2000, pp. 44-49
Evaluation of botulinum toxin A therapy in children with adductor spasm bygross motor function measure
Authors: Mall, V Heinen, F Kirschner, J Linder, M Stein, S Michaelis, U Bernius, P Lane, M Korinthenberg, R
Citation: V. Mall et al., Evaluation of botulinum toxin A therapy in children with adductor spasm bygross motor function measure, J CHILD NEU, 15(4), 2000, pp. 214-217
Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy
Authors: Herrmann, J Mall, V Bigalke, H Geth, K Korinthenberg, R Heinen, F
Citation: J. Herrmann et al., Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy, NEUROPEDIAT, 31(6), 2000, pp. 333-334
CNS lipoma in patients with epidermal nevus syndrome
Authors: Mall, V Heinen, F Uhl, M Wellens, E Korinthenberg, R
Citation: V. Mall et al., CNS lipoma in patients with epidermal nevus syndrome, NEUROPEDIAT, 31(4), 2000, pp. 175-179
Development of the corticospinal system and hand motor function: central conduction times and motor performance tests
Authors: Fietzek, UM Heinen, F Berweck, S Maute, S Hufschmidt, A Schulte-Monting, A Lucking, CH Korinthenberg, R
Citation: Um. Fietzek et al., Development of the corticospinal system and hand motor function: central conduction times and motor performance tests, DEVELOP MED, 42(4), 2000, pp. 220-227
Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome
Authors: Heinen, F Linder, M Mall, V Kirschner, J Korinthenberg, R
Citation: F. Heinen et al., Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome, EUR J NEUR, 6, 1999, pp. S47-S50
GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany
Authors: Kamm, C Castelon-Konkiewitz, E Naumann, M Heinen, F Brack, M Nebe, A Ceballos-Baumann, A Gasser, T
Citation: C. Kamm et al., GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany, MOVEMENT D, 14(4), 1999, pp. 681-683
Lack of response to botulinum toxin A in patients with hypertrophic pyloric stenosis
Authors: Heinen, F Mall, V Ruckauer, KD Greiner, P Sontheimer, J Brandis, M Korinthenberg, R
Citation: F. Heinen et al., Lack of response to botulinum toxin A in patients with hypertrophic pyloric stenosis, EUR J PED, 158(5), 1999, pp. 436-436
Pediatric neurology on the threshold of a new millenium
Authors: Voit, T Abe, T Antunes, NL Aso, K Beck, M Becker, LE Berthet, F Bourgeois, B Braddick, O Cioni, G Cowan, F DiFazio, MP DiMauro, S Dodge, N Enders, G Forsting, N Frahm, J Futagi, Y Gabreels-Festen, A Gartner, J Gillessen-Kaesbach, G Golden, J Greisen, G Guichenai, P Hagberg, B Heinen, F Hohlfeld, R Holmes, GL Inoue, Y Iwamoto, H Jaeken, J Kaufmann, W Kimura, H Kohyama, J Korinthenberg, R Kramer, H Kreth, W Krivit, W Logan, W Lorenz, B Lou, H Martin, JJ Matshushima, Y Munnich, A Naidu, S Neubauer, W Oguni, H Oka, E Osawa, M Panayiotopoulos, CP Partridge, T Raemaekers, V Rapin, I Reis, A Rivkin, M Roll, C Rosenbaum, T Ross, E Rotteveel, J Schroder, JM Seitz, R Soul, J Steinlein, O Stephani, U Tanaka, J Taylor, G Tome, F Topcu, N Tuxhorn, I Urlesberger, B Wahn, V Wenk, G Wilichowski, E Wraith, JE Wynshaw-Boris, A
Citation: T. Voit et al., Pediatric neurology on the threshold of a new millenium, NEUROPEDIAT, 30(6), 1999, pp. 277-277
Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized double-blind study of "high dose" versus "low-dose" treatment
Authors: Wissel, J Heinen, F Schenkel, A Doll, B Ebersbach, G Muller, J Poewe, W
Citation: J. Wissel et al., Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized double-blind study of "high dose" versus "low-dose" treatment, NEUROPEDIAT, 30(3), 1999, pp. 120-124
Facial nerve dysfunction in hereditary motor and sensory neuropathy type Iand III
Authors: Glocker, FX Rosler, KM Linden, D Heinen, F Hess, CW Lucking, CH
Citation: Fx. Glocker et al., Facial nerve dysfunction in hereditary motor and sensory neuropathy type Iand III, MUSCLE NERV, 22(9), 1999, pp. 1201-1208
Absence of transcallosal inhibition in adolescents with diplegic cerebral palsy
Authors: Heinen, F Kirschner, J Fietzek, U Glocker, FX Mall, V Korinthenberg, R
Citation: F. Heinen et al., Absence of transcallosal inhibition in adolescents with diplegic cerebral palsy, MUSCLE NERV, 22(2), 1999, pp. 255-257
Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenterstudy comprising 204 patients (vol 111, pg 837, 1999)
Authors: Wissel, J Muller, J Heinen, F Mall, V Sojer, M Ebersbach, G Poewe, W
Citation: J. Wissel et al., Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenterstudy comprising 204 patients (vol 111, pg 837, 1999), WIEN KLIN W, 111(24), 1999, pp. 1051-1051
Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenterstudy comprising 204 patients
Authors: Wissel, J Muller, J Heinen, F Mall, V Sojer, M Ebersbach, G Poewe, W
Citation: J. Wissel et al., Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenterstudy comprising 204 patients, WIEN KLIN W, 111(20), 1999, pp. 837-842
Risultati: 1-19 |